← Back to Search

Speech and Exercise Therapy for Parkinson's Disease

N/A

Recruiting

Led By David William Sparrow, DSc

Research Sponsored by VA Office of Research and Development

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Hypokinetic dysarthria

Physician diagnosis of idiopathic Parkinson's disease (PD)

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 6 months

Awards & highlights

Study Summary

This trial will test whether a combination of speech and exercise training can improve speech intelligibility for people with Parkinson's disease and speech impairment. The findings may help VA clinicians provide better care for Veterans with these conditions.

Who is the study for?

This trial is for people with Parkinson's disease who have speech and voice disorders known as hypokinetic dysarthria. Participants must have a diagnosis of idiopathic PD, show at least two key symptoms (resting tremor, rigidity, bradykinesia), and respond to medication for PD. Those with recent heart issues or requiring therapy for irregular heartbeat cannot join.Check my eligibility

What is being tested?

The study is testing if a combined speech and exercise program can help improve how well people with Parkinson's can speak and be understood. It compares this approach to standard health education. The intervention will be delivered through telemedicine, which could make long-term care more accessible.See study design

What are the potential side effects?

Since the interventions involve speech exercises and health education rather than medications or invasive procedures, significant side effects are not expected. However, participants may experience fatigue or discomfort from the exercises.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I have a speech disorder due to muscle weakness.

Select...

I have been diagnosed with Parkinson's disease by a doctor.

Select...

I show at least 2 key Parkinson's symptoms (shaking, stiffness, slow movement).

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 6 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~6 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Speech Intelligibility

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Combined speech and exercise interventionExperimental Treatment1 Intervention

Home-based exercise intervention with interactive automated speech response features that encourage a higher level of speech performance.

Group II: Control groupActive Control1 Intervention

Health education

0 / 3Eligibility criteria met

Find a Location

Who is running the clinical trial?

VA Office of Research and DevelopmentLead Sponsor

1,610 Previous Clinical Trials

3,305,080 Total Patients Enrolled

David William Sparrow, DScPrincipal InvestigatorVA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA

8 Previous Clinical Trials

1,307 Total Patients Enrolled

Media Library

Combined speech and exercise intervention Clinical Trial Eligibility Overview. Trial Name: NCT04617496 — N/A

Parkinson's Disease Research Study Groups: Combined speech and exercise intervention, Control group

Parkinson's Disease Clinical Trial 2023: Combined speech and exercise intervention Highlights & Side Effects. Trial Name: NCT04617496 — N/A

Combined speech and exercise intervention 2023 Treatment Timeline for Medical Study. Trial Name: NCT04617496 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many participants are eligible to join the current clinical trial?

"Affirmative. According to the information displayed on clinicialtrials.gov, this medical trial is presently recruiting participants and has been since July 1st 2021. The study requires 104 patients from only one site for completion."

Answered by AI

Are there any remaining vacancies for people to partake in this experiment?

"Per the information available on clinicaltrials.gov, this research initiative is open for recruitment and was originally posted on 7/1/2021 with its most recent amendment issued 6/22/2022."

Answered by AI

Is eligibility for the research study restricted to individuals over 50 years of age?

"This trial is specified for those aged between 40 and 89 years old. For comparison, there are 29 clinical trials that involve participants below 18 and 491 studies open to patients over 65."

Answered by AI

Is my profile compatible with the qualifications for this medical experiment?

"To be eligible for the clinical trial, applicants must have Parkinson's disease and a date of birth between 40-89 years old. The team are looking to recruit 104 volunteers in total."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

An RCT of a Telemedicine Intervention for Hypokinetic Dysarthria in PD

2021. "An RCT of a Telemedicine Intervention for Hypokinetic Dysarthria in PD". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04617496.